Lapelga (pegfilgrastim)

pCPA File Number: 21054

Negotiation Status:

Concluded with an LOI

Indication(s):

Febrile Neutropenia

Sponsor/Manufacturer:

Apobiologix, a Division of Apotex Inc.

CDA-AMC Project Number:

SE0555-000

pCPA Engagement Letter Issued:

2018-10-10

Negotiation Process Concluded:

2019-02-28